VICKS SINEX 12 HOUR ULTRAFINE MIST

Compare VICKS SINEX 12 HOUR ULTRAFINE MIST  to:
Compare
Compare

Generic Name for VICKS SINEX 12 HOUR ULTRAFINE MIST

Oxymetazoline HCl 0.05%; nasal spray; contains benzalkonium chloride, camphor, eucalyptol, menthol.

Legal Classification:

OTC

Pharmacological Class for VICKS SINEX 12 HOUR ULTRAFINE MIST

Sympathomimetic.

Manufacturer of VICKS SINEX 12 HOUR ULTRAFINE MIST

Procter & Gamble Pharmaceuticals

Indications for VICKS SINEX 12 HOUR ULTRAFINE MIST

Nasal congestion.

Adults and Children:

<6yrs: not recommended. ≥6yrs: 2–3 sprays in each nostril not more than every 10–12hrs; max 2 doses/24hrs for 3 days.

Also:

Contraindications for VICKS SINEX 12 HOUR ULTRAFINE MIST

Children <2yrs old.

Warnings/Precautions for VICKS SINEX 12 HOUR ULTRAFINE MIST

Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Pregnancy. Nursing mothers.

Adverse Reactions for VICKS SINEX 12 HOUR ULTRAFINE MIST

Nasal discomfort (eg, burning, stinging, sneezing), rebound congestion.

How is VICKS SINEX 12 HOUR ULTRAFINE MIST supplied?

Spray—15mL

Related Disease:

Congestion, nasal~nasal preparations

Related Resources

McNeil Consumer Healthcare product supply update

June 25, 2010

McNeil Consumer Healthcare announced that it does not anticipate having sources of supply for most of the products that were produced at its Fort Washington, Pennsylvania manufacturing facility before the end of 2010.

Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray recalled

June 24, 2010

Procter & Gamble announced a voluntary nationwide recall of Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray (oxymetazoline HCl).

Four PediaCare products recalled

June 01, 2010

The FDA and Blacksmith Brands notified healthcare professionals and consumers of a nationwide voluntary recall of all lots of four PediaCare children's products.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Children's and Infants' liquid Tylenol, Motrin, Zyrtec, and Benadryl recalled

May 03, 2010

The FDA and McNeil Consumer Healthcare have notified healthcare professionals of a voluntary recall of certain over-the-counter (OTC) Children's and Infant's liquid Tylenol, Motrin, Zyrtec, and Benadryl products.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions